Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Leukemia Research|April 20, 2016
Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid LeukemiaLalit Saini, Joseph Brandwein, Robert Turner, et al.Blood|April 15, 2020
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover studyGuillermo Garcia-Manero, Elizabeth A Griffiths, David P Steensma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignanciesAaron D Schimmer, Susan O'Brien, Hagop Kantarjian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemiaEric J Feldman, Joseph Brandwein, Richard Stone, et al.Investigational New Drugs|July 14, 2016
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemiaKaren W L Yee, Hsiao-Wei T Chen, David W Hedley, et al.The Lancet. Haematology|October 11, 2025
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trialGuillaume Richard-Carpentier, Gopila Gupta, Charina Koraksic, et al.British Journal of Haematology|October 11, 2014
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosisKevin H M Kuo, Jeannie L Callum, Tony Panzarella, et al.Bone Marrow Transplantation|April 2, 2020
Curability and transferability of atopy with allogeneic hematopoietic cell transplantationSarah Whiteside, Alex Chin, Gaurav Tripathi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemiaAaron D Schimmer, Elihu H Estey, Gautam Borthakur, et al.Blood|February 3, 2005
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cellsBing Z Carter, Marcela Gronda, Zhiliang Wang, et al.Pageof 8